INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT

Clinical trials for INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT explained in plain language.

Never miss a new study

Get alerted when new INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT trials appear

Sign up with your email to follow new studies for INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Triple-Threat attack on tough bladder cancers

Disease control Ongoing

This early-stage trial is testing the safety and best dose of a three-drug combination for patients with advanced bladder cancer that has spread or cannot be removed by surgery. The treatment combines two immunotherapy drugs that help the immune system fight cancer with a third d…

Matched conditions: INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT

Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT

Get alerted when new INFILTRATING UROTHELIAL CARCINOMA, SARCOMATOID VARIANT trials appear

Scientists test Triple-Threat attack on tough bladder cancers